The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
about
Independent and combined influence of AGTR1 variants and aerobic exercise on oxidative stress in hypertensives.The relationship of oxidative stress and cholesterol with dipping status before and after aerobic exercise trainingEffect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women.Selenium Digestibility and Bioactivity in Dogs: What the Can Can, the Kibble Can't.Clinical and research markers of oxidative stress in chronic kidney disease.
P2860
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@en
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@nl
type
label
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@en
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@nl
prefLabel
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@en
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@nl
P2860
P1476
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.
@en
P2093
P2860
P356
10.1080/17482970701411642
P577
2007-06-01T00:00:00Z